121 related articles for article (PubMed ID: 8478310)
21. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin.
Jooné GK; Van Rensburg CE; Anderson R
J Antimicrob Chemother; 1992 Oct; 30(4):509-23. PubMed ID: 1337069
[TBL] [Abstract][Full Text] [Related]
22. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
[TBL] [Abstract][Full Text] [Related]
23. Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa.
Rutman A; Dowling R; Wills P; Feldman C; Cole PJ; Wilson R
Antimicrob Agents Chemother; 1998 Apr; 42(4):772-8. PubMed ID: 9559781
[TBL] [Abstract][Full Text] [Related]
24. Tonsillar tissue penetration of dirithromycin after multiple doses.
Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
[TBL] [Abstract][Full Text] [Related]
25. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
Pfaller MA; Jones RN; Washington JA; Koontz FP; Gerlach EH; Erwin ME
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):145-50. PubMed ID: 1315231
[TBL] [Abstract][Full Text] [Related]
26. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
Maskell JP; Sefton AM; Williams JD
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
[TBL] [Abstract][Full Text] [Related]
27. In vitro interaction between dirithromycin or its metabolite, erythromycylamine, and oxidative polymorphonuclear metabolism.
Moutard I; Gressier B; Brunet C; Dine T; Luyckx M; Cazin M; Cazin JC
J Antibiot (Tokyo); 1997 Jan; 50(1):53-7. PubMed ID: 9066766
[TBL] [Abstract][Full Text] [Related]
28. Effect of medium pH on the activity of dirithromycin and erythromycylamine in Bactec broth against Mycobacterium avium complex.
Moinard D; Bourried Y; Bemer-Melchior P
J Antimicrob Chemother; 1994 Oct; 34(4):597-8. PubMed ID: 7868412
[No Abstract] [Full Text] [Related]
29. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation.
Abdelghaffar H; Mtairag EM; Labro MT
Antimicrob Agents Chemother; 1994 Jul; 38(7):1548-54. PubMed ID: 7979287
[TBL] [Abstract][Full Text] [Related]
30. Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility tests.
Barry AL; Fuchs PC; Brown SD
J Antimicrob Chemother; 2001 Jul; 48(1):121-5. PubMed ID: 11418522
[TBL] [Abstract][Full Text] [Related]
31. Dirithromycin: a new macrolide.
Wintermeyer SM; Abdel-Rahman SM; Nahata MC
Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
[TBL] [Abstract][Full Text] [Related]
32. Preparation of stock solutions of macrolide and ketolide compounds for antimicrobial susceptibility tests.
Barry A; Bryskier A; Traczewski M; Brown S
Clin Microbiol Infect; 2004 Jan; 10(1):78-83. PubMed ID: 14706092
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of dirithromycin.
Sides GD; Cerimele BJ; Black HR; Busch U; DeSante KA
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():65-75. PubMed ID: 8478313
[TBL] [Abstract][Full Text] [Related]
34. Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test.
Barry AL; Fernandes PB; Jorgensen JH; Thornsberry C; Hardy DJ; Jones RN
J Clin Microbiol; 1988 Nov; 26(11):2415-20. PubMed ID: 2976773
[TBL] [Abstract][Full Text] [Related]
35. Reproducibility of disc susceptibility tests with Haemophilus influenzae.
Barry AL; Jorgensen JH; Hardy DJ
J Antimicrob Chemother; 1991 Mar; 27(3):295-301. PubMed ID: 2037535
[TBL] [Abstract][Full Text] [Related]
36. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
Hamilton-Miller JM
J Antimicrob Chemother; 1992 Feb; 29(2):141-7. PubMed ID: 1506329
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility testing of macrolide and lincosamide antibiotics according to DIN guidelines. Deutsches Institut für Normung.
Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Schlenk R; Vanca E; Wildfeuer A
J Antimicrob Chemother; 1997 Aug; 40(2):179-87. PubMed ID: 9301982
[TBL] [Abstract][Full Text] [Related]
38. Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.
Barry AL; Jorgensen JH; Hardy DJ; Allen SD; Baker CN; Fuchs PC; McLaughlin JC
J Clin Microbiol; 1992 Nov; 30(11):3013-5. PubMed ID: 1333487
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System.
Periti P; Nicoletti P; Novelli A
Chemioterapia; 1985 Apr; 4(2):156-60. PubMed ID: 3924422
[TBL] [Abstract][Full Text] [Related]
40. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
Fuchs PC; Barry AL; Brown SD
J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
